Skip to main content
Equibles

Blake Byers

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Blake Byers

Earlier roles on record: Board Member at Dianthus Therapeutics, Inc. /DE/ (DNTH) until June 1, 2021 and Board Member at IonQ, Inc. (IONQ) until December 7, 2022. IonQ, Inc. reported in an 8-K filed December 9, 2022 that Blake Byers resigned as Class I director, effective December 7, 2022.

“On December 5, 2022, Blake Byers, a Class I director of IonQ, Inc. (the "Company"), informed the Company of his decision to resign from his role on the Company's board of directors (the "Board") effective December 7, 2022.”
IonQ, Inc. Form 8-K, filed December 9, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.